BR0003105A - Compostos de beta-carbolina, processo para sua preparação e composições farmacêuticas contendo os mesmos - Google Patents
Compostos de beta-carbolina, processo para sua preparação e composições farmacêuticas contendo os mesmosInfo
- Publication number
- BR0003105A BR0003105A BR0003105-4A BR0003105A BR0003105A BR 0003105 A BR0003105 A BR 0003105A BR 0003105 A BR0003105 A BR 0003105A BR 0003105 A BR0003105 A BR 0003105A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- same
- beta
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Patente de Invenção: <B>"COMPOSTOS DE BETA-CARBOLINA, PROCESSO PARA SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS"<D>. Compostos de fórmula (I): onde: <sym>representa uma ligação simples ou dupla, R~ 1~ representa um átomo de hidrogênio, um grupo alquila, um grupo -R~ 6~-arila, um grupo -R~ 6~-cicloalquila, um -R~ 6~-heterociclo, -CO~ 2~R~ 7~-, -COR~ 8~ ou -CONHR~ 8~ onde R~ 6~, R~ 7~ e R~ 8~ são como definidos no relatório descritivo, R~ 2~ representa um grupo ciano, um grupo mono ou dialquilaminoalquilaminocarbonila, ou -CO~ 2~R~ 8~, -CONHR~ 8~, -NR~ 8~R~ 9~, -NHCO~ 2~R~ 7~ ou -COR~ 8~ onde R~ 7~, R~ 8~ e R~ 9~ são como definidos no relatório descritivo, R~ 3~ e R~ 4~ juntos formam um grupo (C~ 3~-C~ 10~) cicloalquila, R~ 5~ representa um átomo de hidrogênio ou um grupo alquila ou arilalquila, Ra, Rb, Rc, Rd, que podem ser iguais ou diferentes, representam um grupo como definido no relatório descritivo, seus isómeros, e sais de adição dos mesmos com um ácido ou base farmaceuticamente aceitável. Medicamentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9909576A FR2796644B1 (fr) | 1999-07-23 | 1999-07-23 | Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0003105A true BR0003105A (pt) | 2001-03-13 |
Family
ID=9548447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0003105-4A BR0003105A (pt) | 1999-07-23 | 2000-07-24 | Compostos de beta-carbolina, processo para sua preparação e composições farmacêuticas contendo os mesmos |
Country Status (16)
Country | Link |
---|---|
US (1) | US6350757B1 (pt) |
EP (1) | EP1070716A1 (pt) |
JP (1) | JP2001072679A (pt) |
KR (1) | KR20010049859A (pt) |
CN (1) | CN1282743A (pt) |
AU (1) | AU762958B2 (pt) |
BR (1) | BR0003105A (pt) |
CA (1) | CA2314473A1 (pt) |
EA (1) | EA004140B1 (pt) |
FR (1) | FR2796644B1 (pt) |
HU (1) | HUP0002843A3 (pt) |
MX (1) | MXPA00007058A (pt) |
NO (1) | NO20003764L (pt) |
NZ (1) | NZ505903A (pt) |
PL (1) | PL341549A1 (pt) |
ZA (1) | ZA200003702B (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74826C2 (en) * | 2000-05-17 | 2006-02-15 | Ortho Mcneil Pharm Inc | ?-carboline derivatives as phosphodiesterase inhibitors |
US20040253891A1 (en) * | 2000-09-12 | 2004-12-16 | Schierenbeck Alan W. | Composite structure for protective garment |
TWI329111B (en) | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
CA2524125A1 (en) * | 2003-04-29 | 2004-11-11 | Oscient Pharmaceuticals | Antibiotic tetrahydro-.beta.-carboline derivatives |
WO2004113300A1 (ja) * | 2003-06-23 | 2004-12-29 | Ono Pharmaceutical Co., Ltd. | 新規三環性複素環化合物 |
US20050143371A1 (en) * | 2003-07-23 | 2005-06-30 | Pharmacia Corporation | Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
CA2554150A1 (en) | 2004-01-23 | 2005-08-04 | Chiron Corporation | Tetrahydrocarboline compounds as anticancer agents |
US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
PL1737461T3 (pl) | 2004-03-15 | 2013-05-31 | Ptc Therapeutics Inc | Pochodne karbolinowe użyteczne w hamowaniu angiogenezy |
US7767689B2 (en) * | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
WO2006068164A1 (ja) | 2004-12-22 | 2006-06-29 | Ono Pharmaceutical Co., Ltd. | 三環式化合物およびその用途 |
FR2901795A1 (fr) * | 2006-05-30 | 2007-12-07 | Fourtillan Snc | Derives de pyrimidino[1',6'-1,2]pyrido[3,4-b]indoles et leur utilisation en therapeutique |
FR2908768A1 (fr) * | 2006-06-19 | 2008-05-23 | Fourtillan Snc | DERIVES DE 3H,11H-OXAZOLO (3',4':1,2)PYRIDO(3,4-b)INDOLE ET LEUR UTILISATION EN THERAPEUTIQUE |
FR2912405A1 (fr) * | 2007-02-08 | 2008-08-15 | Fourtillan Snc | Derives des imidazo[1',5':1,6]pyrido[3,4-b]indoles et leur utilisation en therapeutique |
JP2010540439A (ja) * | 2007-09-20 | 2010-12-24 | ディー2イー,エルエルシー | 神経保護性の及び認知を向上させる性質を備えた水素化されたピリド[4,3−b]インドール類のフッ素を含有する誘導体、調製するための工程、並びに使用 |
JP2011505373A (ja) * | 2007-11-30 | 2011-02-24 | ビオタ サイエンティフィック マネージメント ピーティーワイ リミテッド | 抗菌剤としての2環式ppat阻害剤 |
PL2262505T3 (pl) * | 2008-03-12 | 2015-04-30 | Intra Cellular Therapies Inc | Podstawione heterocykliczne skondensowane gamma-karboliny w postaci stałej |
PE20091717A1 (es) | 2008-03-24 | 2009-11-25 | Medivation Technologies Inc | Pirido[3,4-b] indoles como moduladores de receptores de histamina |
DE102008025893B4 (de) * | 2008-05-26 | 2014-09-18 | Technische Universität Dresden | Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren |
BR112012006646A2 (pt) * | 2009-09-23 | 2019-09-24 | Medivation Technologies Inc | composto, composição farmacêutica, método de tratamento de um distùrbio cognitivo, distúrbio psicótico, distúrbio mediado por neurotransmissor ou um distúrbio neuronal e kit |
CN102711467A (zh) * | 2009-09-23 | 2012-10-03 | 梅迪维新技术公司 | 吡啶并[3,4-b]吲哚类及使用方法 |
BR112013021126A2 (pt) | 2011-02-18 | 2019-09-24 | Medivation Technologies Inc | método para reduzir a pressão sanguínea, método para aumentar o fluxo sanguíneo renal ou diminuir a reabsorção de sódio, método para tratar uma doença, kit, composto e composição farmacêutica |
ES2587856T3 (es) | 2011-03-18 | 2016-10-27 | Ono Pharmaceutical Co., Ltd. | Derivado de tetrahidrocarbolina |
KR101534523B1 (ko) * | 2013-04-30 | 2015-07-09 | 경희대학교 산학협력단 | 1,2,3,4-테트라히드로-6-메톡시-1-옥소-베타-카르볼린을 포함하는 피부 미백용 화장료 조성물 |
EP3004090B1 (en) * | 2013-05-28 | 2017-10-25 | Astrazeneca AB | Chemical compounds |
WO2020072675A1 (en) * | 2018-10-02 | 2020-04-09 | Northwestern University | Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c) |
US10947253B2 (en) | 2019-08-05 | 2021-03-16 | Ankh Life Sciences Limited | Fused polycyclic dimers |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR205452A1 (es) * | 1973-12-06 | 1976-05-07 | Endo Lab | Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles |
FR2455044A1 (fr) * | 1979-04-26 | 1980-11-21 | Synthelabo | Pyrido-indoles et leur application en therapeutique |
JP2527319B2 (ja) * | 1986-12-25 | 1996-08-21 | 川研ファインケミカル株式会社 | 7―ブロモ―β―カルボリン誘導体の製造方法 |
US5300645A (en) * | 1993-04-14 | 1994-04-05 | Eli Lilly And Company | Tetrahydro-pyrido-indole |
EP0620222A3 (en) * | 1993-04-14 | 1995-04-12 | Lilly Co Eli | Tetrahydro-beta-carbolines. |
US5663178A (en) * | 1995-02-06 | 1997-09-02 | Eli Lilly And Company | Tetrahydro-beta carbolines |
US5688807A (en) * | 1994-03-11 | 1997-11-18 | Eli Lilly And Company | Method for treating 5HT2B receptor related conditions |
-
1999
- 1999-07-23 FR FR9909576A patent/FR2796644B1/fr not_active Expired - Fee Related
-
2000
- 2000-07-19 MX MXPA00007058A patent/MXPA00007058A/es unknown
- 2000-07-19 JP JP2000218942A patent/JP2001072679A/ja active Pending
- 2000-07-19 PL PL00341549A patent/PL341549A1/xx not_active Application Discontinuation
- 2000-07-20 CA CA002314473A patent/CA2314473A1/fr not_active Abandoned
- 2000-07-21 NZ NZ505903A patent/NZ505903A/en unknown
- 2000-07-21 US US09/621,742 patent/US6350757B1/en not_active Expired - Fee Related
- 2000-07-21 NO NO20003764A patent/NO20003764L/no unknown
- 2000-07-21 EP EP00402073A patent/EP1070716A1/fr not_active Withdrawn
- 2000-07-21 AU AU48769/00A patent/AU762958B2/en not_active Ceased
- 2000-07-21 EA EA200000700A patent/EA004140B1/ru not_active IP Right Cessation
- 2000-07-21 HU HU0002843A patent/HUP0002843A3/hu unknown
- 2000-07-21 ZA ZA200003702A patent/ZA200003702B/xx unknown
- 2000-07-21 CN CN00121615A patent/CN1282743A/zh active Pending
- 2000-07-24 KR KR1020000042401A patent/KR20010049859A/ko not_active Application Discontinuation
- 2000-07-24 BR BR0003105-4A patent/BR0003105A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA00007058A (es) | 2002-04-24 |
EA004140B1 (ru) | 2004-02-26 |
CA2314473A1 (fr) | 2001-01-23 |
NO20003764L (no) | 2001-01-24 |
FR2796644A1 (fr) | 2001-01-26 |
NZ505903A (en) | 2001-08-31 |
PL341549A1 (en) | 2001-01-29 |
FR2796644B1 (fr) | 2001-09-07 |
US6350757B1 (en) | 2002-02-26 |
JP2001072679A (ja) | 2001-03-21 |
KR20010049859A (ko) | 2001-06-15 |
HUP0002843A3 (en) | 2001-07-30 |
EP1070716A1 (fr) | 2001-01-24 |
CN1282743A (zh) | 2001-02-07 |
AU4876900A (en) | 2001-01-25 |
HUP0002843A2 (hu) | 2001-04-28 |
ZA200003702B (en) | 2001-05-21 |
EA200000700A3 (ru) | 2001-04-23 |
HU0002843D0 (en) | 2000-09-28 |
NO20003764D0 (no) | 2000-07-21 |
EA200000700A2 (ru) | 2001-02-26 |
AU762958B2 (en) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0003105A (pt) | Compostos de beta-carbolina, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
ATE469136T1 (de) | Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1 | |
BR0214344A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
ES2185307T3 (es) | Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion. | |
BRPI0507830A (pt) | derivados azabicìclicos, o respectivo processo de preparo e as composições farmacêuticas que os contêm | |
HN2003000184A (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
BRPI0408240A (pt) | composto, utilização de um composto e composição farmacêutica | |
AR027360A1 (es) | Composicion farmaceutica | |
SE9904421D0 (sv) | New compounds | |
NO20055601L (no) | Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer | |
BR0308765A (pt) | Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7 | |
BR0100234A (pt) | Compostos de piperidina-4-sulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR9916669A (pt) | Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias | |
AR037521A1 (es) | Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion | |
BRPI0411308A8 (pt) | Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
BR0013582A (pt) | Agonistas retinóides seletivos para rar | |
BR0308807A (pt) | Compostos tiazol-2-il-imina como inibidores de pde-7 | |
BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BR0005557A (pt) | Compostos diidrofuro[3,4-b] quinolin-1-ona, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos | |
BR0300698A (pt) | Compostos derivados de quinazolina, um processo para sua preparação e composições farmacêuticas contendo-os | |
BR0202681A (pt) | Compostos de octaidro-2h-pirido[1,2a]pirazina, um processo para sua preparação e composições farmacêuticas contendo-as | |
BR9804485A (pt) | Compostos de indanol, processo para sua preparação e composições farmacêuticas contendo os mesmos. | |
ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
BR9800763A (pt) | Novos compostos 2-amino indano, um processo para sua preparação e composições farmacêuticas contendo os mesmos. | |
SE0101978D0 (sv) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: LES LABORATOIRES SERVIER (FR) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |